ARCHIVES

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Three researchers share Paul Marks Prize.

November 11, 2005

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003

In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks

July 30, 1982